nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Gefitinib—lung cancer	0.0218	0.32	CbGbCtD
Quinidine barbiturate—CYP2D6—Vinorelbine—lung cancer	0.0168	0.246	CbGbCtD
Quinidine barbiturate—CYP2D6—Erlotinib—lung cancer	0.0129	0.189	CbGbCtD
Quinidine barbiturate—CYP2D6—Vinblastine—lung cancer	0.0103	0.152	CbGbCtD
Quinidine barbiturate—CYP2D6—Doxorubicin—lung cancer	0.00636	0.0933	CbGbCtD
Quinidine barbiturate—Phenobarbital—ABCC3—lung cancer	0.00263	0.141	CrCbGaD
Quinidine barbiturate—Quinine—CYP2E1—lung cancer	0.00255	0.137	CrCbGaD
Quinidine barbiturate—Quinine—CYP1A1—lung cancer	0.00251	0.135	CrCbGaD
Quinidine barbiturate—Quinidine—CYP2E1—lung cancer	0.00224	0.12	CrCbGaD
Quinidine barbiturate—Quinidine—CYP1A1—lung cancer	0.00221	0.119	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP2A6—lung cancer	0.00143	0.0767	CrCbGaD
Quinidine barbiturate—Quinine—ABCB1—lung cancer	0.00134	0.0717	CrCbGaD
Quinidine barbiturate—Quinidine—ABCB1—lung cancer	0.00117	0.063	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP2E1—lung cancer	0.00101	0.0545	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP1A1—lung cancer	0.001	0.0537	CrCbGaD
Quinidine barbiturate—Phenobarbital—ABCB1—lung cancer	0.000532	0.0286	CrCbGaD
Quinidine barbiturate—Hypotension—Etoposide—lung cancer	0.00033	0.000456	CcSEcCtD
Quinidine barbiturate—Pain—Cisplatin—lung cancer	0.000329	0.000455	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000329	0.000454	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Doxorubicin—lung cancer	0.000328	0.000454	CcSEcCtD
Quinidine barbiturate—Vomiting—Vinorelbine—lung cancer	0.000327	0.000452	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Gemcitabine—lung cancer	0.000327	0.000451	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—lung cancer	0.000326	0.00045	CcSEcCtD
Quinidine barbiturate—Rash—Vinorelbine—lung cancer	0.000324	0.000448	CcSEcCtD
Quinidine barbiturate—Dermatitis—Vinorelbine—lung cancer	0.000324	0.000448	CcSEcCtD
Quinidine barbiturate—Hypotension—Paclitaxel—lung cancer	0.000323	0.000447	CcSEcCtD
Quinidine barbiturate—Headache—Vinorelbine—lung cancer	0.000322	0.000445	CcSEcCtD
Quinidine barbiturate—Syncope—Docetaxel—lung cancer	0.000322	0.000445	CcSEcCtD
Quinidine barbiturate—Asthma—Doxorubicin—lung cancer	0.000322	0.000445	CcSEcCtD
Quinidine barbiturate—Leukopenia—Docetaxel—lung cancer	0.000322	0.000444	CcSEcCtD
Quinidine barbiturate—Sweating—Methotrexate—lung cancer	0.000318	0.000439	CcSEcCtD
Quinidine barbiturate—Palpitations—Docetaxel—lung cancer	0.000318	0.000439	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Cisplatin—lung cancer	0.000317	0.000439	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Docetaxel—lung cancer	0.000316	0.000436	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000315	0.000436	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Etoposide—lung cancer	0.000315	0.000435	CcSEcCtD
Quinidine barbiturate—Somnolence—Etoposide—lung cancer	0.000314	0.000433	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Doxorubicin—lung cancer	0.000314	0.000433	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Irinotecan—lung cancer	0.000313	0.000432	CcSEcCtD
Quinidine barbiturate—Convulsion—Docetaxel—lung cancer	0.000311	0.00043	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—lung cancer	0.000309	0.000427	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Paclitaxel—lung cancer	0.000308	0.000426	CcSEcCtD
Quinidine barbiturate—Somnolence—Paclitaxel—lung cancer	0.000308	0.000425	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Etoposide—lung cancer	0.000307	0.000424	CcSEcCtD
Quinidine barbiturate—Arthralgia—Docetaxel—lung cancer	0.000306	0.000423	CcSEcCtD
Quinidine barbiturate—Myalgia—Docetaxel—lung cancer	0.000306	0.000423	CcSEcCtD
Quinidine barbiturate—Chest pain—Docetaxel—lung cancer	0.000306	0.000423	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Doxorubicin—lung cancer	0.000306	0.000422	CcSEcCtD
Quinidine barbiturate—Nausea—Vinorelbine—lung cancer	0.000306	0.000422	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Etoposide—lung cancer	0.000305	0.000421	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Cisplatin—lung cancer	0.000305	0.000421	CcSEcCtD
Quinidine barbiturate—Asthenia—Irinotecan—lung cancer	0.000304	0.000421	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000304	0.00042	CcSEcCtD
Quinidine barbiturate—Constipation—Etoposide—lung cancer	0.000302	0.000417	CcSEcCtD
Quinidine barbiturate—Pain—Etoposide—lung cancer	0.000302	0.000417	CcSEcCtD
Quinidine barbiturate—Neutropenia—Doxorubicin—lung cancer	0.000301	0.000416	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Paclitaxel—lung cancer	0.000301	0.000416	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Methotrexate—lung cancer	0.000299	0.000413	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000299	0.000413	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—lung cancer	0.000298	0.000411	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—lung cancer	0.000298	0.000411	CcSEcCtD
Quinidine barbiturate—Asthenia—Gemcitabine—lung cancer	0.000297	0.00041	CcSEcCtD
Quinidine barbiturate—Pain—Paclitaxel—lung cancer	0.000296	0.000409	CcSEcCtD
Quinidine barbiturate—Constipation—Paclitaxel—lung cancer	0.000296	0.000409	CcSEcCtD
Quinidine barbiturate—Confusional state—Docetaxel—lung cancer	0.000296	0.000409	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—lung cancer	0.000294	0.000406	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Doxorubicin—lung cancer	0.000294	0.000406	CcSEcCtD
Quinidine barbiturate—Oedema—Docetaxel—lung cancer	0.000293	0.000405	CcSEcCtD
Quinidine barbiturate—Pruritus—Gemcitabine—lung cancer	0.000292	0.000404	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Methotrexate—lung cancer	0.000292	0.000403	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Etoposide—lung cancer	0.000291	0.000402	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Irinotecan—lung cancer	0.00029	0.000401	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Etoposide—lung cancer	0.000289	0.000399	CcSEcCtD
Quinidine barbiturate—Shock—Docetaxel—lung cancer	0.000289	0.000399	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Docetaxel—lung cancer	0.000288	0.000397	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Docetaxel—lung cancer	0.000287	0.000397	CcSEcCtD
Quinidine barbiturate—Drowsiness—Doxorubicin—lung cancer	0.000287	0.000396	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—lung cancer	0.000287	0.000396	CcSEcCtD
Quinidine barbiturate—Tachycardia—Docetaxel—lung cancer	0.000286	0.000395	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Paclitaxel—lung cancer	0.000285	0.000394	CcSEcCtD
Quinidine barbiturate—Skin disorder—Docetaxel—lung cancer	0.000285	0.000394	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000285	0.000393	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Cisplatin—lung cancer	0.000284	0.000392	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000283	0.000391	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Gemcitabine—lung cancer	0.000283	0.000391	CcSEcCtD
Quinidine barbiturate—Renal failure—Doxorubicin—lung cancer	0.000282	0.00039	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Methotrexate—lung cancer	0.000281	0.000389	CcSEcCtD
Quinidine barbiturate—Dizziness—Irinotecan—lung cancer	0.000281	0.000388	CcSEcCtD
Quinidine barbiturate—Urticaria—Etoposide—lung cancer	0.00028	0.000387	CcSEcCtD
Quinidine barbiturate—Jaundice—Doxorubicin—lung cancer	0.00028	0.000386	CcSEcCtD
Quinidine barbiturate—Anorexia—Docetaxel—lung cancer	0.00028	0.000386	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Etoposide—lung cancer	0.000279	0.000385	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Etoposide—lung cancer	0.000279	0.000385	CcSEcCtD
Quinidine barbiturate—Eye disorder—Methotrexate—lung cancer	0.000278	0.000384	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—lung cancer	0.000277	0.000383	CcSEcCtD
Quinidine barbiturate—Asthenia—Cisplatin—lung cancer	0.000276	0.000382	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—lung cancer	0.000276	0.000381	CcSEcCtD
Quinidine barbiturate—Sweating—Doxorubicin—lung cancer	0.000275	0.00038	CcSEcCtD
Quinidine barbiturate—Urticaria—Paclitaxel—lung cancer	0.000275	0.00038	CcSEcCtD
Quinidine barbiturate—Hypotension—Docetaxel—lung cancer	0.000274	0.000379	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Paclitaxel—lung cancer	0.000274	0.000378	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Paclitaxel—lung cancer	0.000274	0.000378	CcSEcCtD
Quinidine barbiturate—Vomiting—Irinotecan—lung cancer	0.00027	0.000373	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Methotrexate—lung cancer	0.000269	0.000371	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—lung cancer	0.000268	0.00037	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Doxorubicin—lung cancer	0.000268	0.00037	CcSEcCtD
Quinidine barbiturate—Rash—Irinotecan—lung cancer	0.000268	0.00037	CcSEcCtD
Quinidine barbiturate—Dermatitis—Irinotecan—lung cancer	0.000267	0.000369	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000267	0.000369	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—lung cancer	0.000267	0.000369	CcSEcCtD
Quinidine barbiturate—Headache—Irinotecan—lung cancer	0.000266	0.000367	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Cisplatin—lung cancer	0.000264	0.000364	CcSEcCtD
Quinidine barbiturate—Vomiting—Gemcitabine—lung cancer	0.000263	0.000363	CcSEcCtD
Quinidine barbiturate—Bradycardia—Doxorubicin—lung cancer	0.000262	0.000362	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Docetaxel—lung cancer	0.000261	0.000361	CcSEcCtD
Quinidine barbiturate—Somnolence—Docetaxel—lung cancer	0.000261	0.00036	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—lung cancer	0.000261	0.00036	CcSEcCtD
Quinidine barbiturate—Rash—Gemcitabine—lung cancer	0.000261	0.00036	CcSEcCtD
Quinidine barbiturate—Dermatitis—Gemcitabine—lung cancer	0.00026	0.00036	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Etoposide—lung cancer	0.00026	0.000359	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—lung cancer	0.000259	0.000358	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—lung cancer	0.000259	0.000358	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—lung cancer	0.000259	0.000358	CcSEcCtD
Quinidine barbiturate—Headache—Gemcitabine—lung cancer	0.000259	0.000358	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—lung cancer	0.000258	0.000356	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—lung cancer	0.000258	0.000356	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Docetaxel—lung cancer	0.000255	0.000352	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Paclitaxel—lung cancer	0.000255	0.000352	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—lung cancer	0.000254	0.000351	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Docetaxel—lung cancer	0.000253	0.00035	CcSEcCtD
Quinidine barbiturate—Asthenia—Etoposide—lung cancer	0.000253	0.00035	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—lung cancer	0.000253	0.000349	CcSEcCtD
Quinidine barbiturate—Nausea—Irinotecan—lung cancer	0.000252	0.000348	CcSEcCtD
Quinidine barbiturate—Pain—Docetaxel—lung cancer	0.000251	0.000346	CcSEcCtD
Quinidine barbiturate—Constipation—Docetaxel—lung cancer	0.000251	0.000346	CcSEcCtD
Quinidine barbiturate—Pruritus—Etoposide—lung cancer	0.00025	0.000345	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—lung cancer	0.000248	0.000343	CcSEcCtD
Quinidine barbiturate—Asthenia—Paclitaxel—lung cancer	0.000248	0.000343	CcSEcCtD
Quinidine barbiturate—Nausea—Gemcitabine—lung cancer	0.000245	0.000339	CcSEcCtD
Quinidine barbiturate—Vomiting—Cisplatin—lung cancer	0.000245	0.000338	CcSEcCtD
Quinidine barbiturate—Pruritus—Paclitaxel—lung cancer	0.000245	0.000338	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—lung cancer	0.000244	0.000337	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—lung cancer	0.000244	0.000337	CcSEcCtD
Quinidine barbiturate—Rash—Cisplatin—lung cancer	0.000243	0.000336	CcSEcCtD
Quinidine barbiturate—Dermatitis—Cisplatin—lung cancer	0.000243	0.000335	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Docetaxel—lung cancer	0.000242	0.000334	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Etoposide—lung cancer	0.000241	0.000334	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—lung cancer	0.000241	0.000333	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—lung cancer	0.00024	0.000332	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Docetaxel—lung cancer	0.00024	0.000331	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—lung cancer	0.000239	0.00033	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—lung cancer	0.000239	0.00033	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Paclitaxel—lung cancer	0.000237	0.000327	CcSEcCtD
Quinidine barbiturate—Dizziness—Etoposide—lung cancer	0.000233	0.000322	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—lung cancer	0.000233	0.000321	CcSEcCtD
Quinidine barbiturate—Vertigo—Methotrexate—lung cancer	0.000233	0.000321	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—lung cancer	0.000232	0.000321	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Docetaxel—lung cancer	0.000232	0.00032	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Docetaxel—lung cancer	0.000232	0.00032	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—lung cancer	0.000232	0.00032	CcSEcCtD
Quinidine barbiturate—Chills—Doxorubicin—lung cancer	0.000231	0.000319	CcSEcCtD
Quinidine barbiturate—Dizziness—Paclitaxel—lung cancer	0.000229	0.000316	CcSEcCtD
Quinidine barbiturate—Nausea—Cisplatin—lung cancer	0.000229	0.000316	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—lung cancer	0.000226	0.000312	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—lung cancer	0.000224	0.00031	CcSEcCtD
Quinidine barbiturate—Vomiting—Etoposide—lung cancer	0.000224	0.00031	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—lung cancer	0.000224	0.00031	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—lung cancer	0.000224	0.00031	CcSEcCtD
Quinidine barbiturate—Rash—Etoposide—lung cancer	0.000223	0.000307	CcSEcCtD
Quinidine barbiturate—Dermatitis—Etoposide—lung cancer	0.000222	0.000307	CcSEcCtD
Quinidine barbiturate—Headache—Etoposide—lung cancer	0.000221	0.000305	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—lung cancer	0.000221	0.000305	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—lung cancer	0.000221	0.000305	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—lung cancer	0.000221	0.000305	CcSEcCtD
Quinidine barbiturate—Tension—Doxorubicin—lung cancer	0.00022	0.000304	CcSEcCtD
Quinidine barbiturate—Vomiting—Paclitaxel—lung cancer	0.00022	0.000304	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000219	0.000303	CcSEcCtD
Quinidine barbiturate—Rash—Paclitaxel—lung cancer	0.000218	0.000301	CcSEcCtD
Quinidine barbiturate—Dermatitis—Paclitaxel—lung cancer	0.000218	0.000301	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—lung cancer	0.000218	0.000301	CcSEcCtD
Quinidine barbiturate—Headache—Paclitaxel—lung cancer	0.000217	0.000299	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Docetaxel—lung cancer	0.000216	0.000299	CcSEcCtD
Quinidine barbiturate—Confusional state—Methotrexate—lung cancer	0.000213	0.000294	CcSEcCtD
Quinidine barbiturate—Vision blurred—Doxorubicin—lung cancer	0.000211	0.000292	CcSEcCtD
Quinidine barbiturate—Asthenia—Docetaxel—lung cancer	0.00021	0.000291	CcSEcCtD
Quinidine barbiturate—Nausea—Etoposide—lung cancer	0.00021	0.00029	CcSEcCtD
Quinidine barbiturate—Pruritus—Docetaxel—lung cancer	0.000207	0.000287	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Methotrexate—lung cancer	0.000207	0.000286	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—lung cancer	0.000207	0.000286	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—lung cancer	0.000206	0.000285	CcSEcCtD
Quinidine barbiturate—Nausea—Paclitaxel—lung cancer	0.000206	0.000284	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—lung cancer	0.000205	0.000284	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—lung cancer	0.000204	0.000282	CcSEcCtD
Quinidine barbiturate—Vertigo—Doxorubicin—lung cancer	0.000201	0.000278	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—lung cancer	0.000201	0.000278	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—lung cancer	0.000201	0.000278	CcSEcCtD
Quinidine barbiturate—Leukopenia—Doxorubicin—lung cancer	0.000201	0.000277	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Docetaxel—lung cancer	0.000201	0.000277	CcSEcCtD
Quinidine barbiturate—Palpitations—Doxorubicin—lung cancer	0.000198	0.000274	CcSEcCtD
Quinidine barbiturate—Hypotension—Methotrexate—lung cancer	0.000198	0.000273	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—lung cancer	0.000197	0.000272	CcSEcCtD
Quinidine barbiturate—Convulsion—Doxorubicin—lung cancer	0.000194	0.000268	CcSEcCtD
Quinidine barbiturate—Dizziness—Docetaxel—lung cancer	0.000194	0.000268	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000193	0.000266	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—lung cancer	0.000191	0.000264	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—lung cancer	0.000191	0.000264	CcSEcCtD
Quinidine barbiturate—Myalgia—Doxorubicin—lung cancer	0.000191	0.000264	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—lung cancer	0.00019	0.000263	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00019	0.000262	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Methotrexate—lung cancer	0.000188	0.00026	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—lung cancer	0.000188	0.00026	CcSEcCtD
Quinidine barbiturate—Vomiting—Docetaxel—lung cancer	0.000186	0.000258	CcSEcCtD
Quinidine barbiturate—Rash—Docetaxel—lung cancer	0.000185	0.000255	CcSEcCtD
Quinidine barbiturate—Dermatitis—Docetaxel—lung cancer	0.000185	0.000255	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—lung cancer	0.000185	0.000255	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Methotrexate—lung cancer	0.000184	0.000254	CcSEcCtD
Quinidine barbiturate—Headache—Docetaxel—lung cancer	0.000184	0.000254	CcSEcCtD
Quinidine barbiturate—Oedema—Doxorubicin—lung cancer	0.000183	0.000253	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—lung cancer	0.000182	0.000252	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—lung cancer	0.000181	0.00025	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—lung cancer	0.00018	0.000249	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—lung cancer	0.00018	0.000248	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—lung cancer	0.000179	0.000248	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—lung cancer	0.000179	0.000247	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—lung cancer	0.000178	0.000246	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—lung cancer	0.000177	0.000244	CcSEcCtD
Quinidine barbiturate—Anorexia—Doxorubicin—lung cancer	0.000174	0.000241	CcSEcCtD
Quinidine barbiturate—Nausea—Docetaxel—lung cancer	0.000174	0.000241	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Methotrexate—lung cancer	0.000174	0.000241	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—lung cancer	0.000173	0.000239	CcSEcCtD
Quinidine barbiturate—Hypotension—Doxorubicin—lung cancer	0.000171	0.000236	CcSEcCtD
Quinidine barbiturate—Urticaria—Methotrexate—lung cancer	0.000168	0.000232	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—lung cancer	0.000167	0.000231	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—lung cancer	0.000167	0.000231	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000167	0.00023	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Doxorubicin—lung cancer	0.000163	0.000225	CcSEcCtD
Quinidine barbiturate—Somnolence—Doxorubicin—lung cancer	0.000163	0.000225	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—lung cancer	0.000159	0.00022	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000158	0.000218	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—lung cancer	0.000157	0.000216	CcSEcCtD
Quinidine barbiturate—Constipation—Doxorubicin—lung cancer	0.000157	0.000216	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Methotrexate—lung cancer	0.000156	0.000215	CcSEcCtD
Quinidine barbiturate—Asthenia—Methotrexate—lung cancer	0.000152	0.00021	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—lung cancer	0.000151	0.000208	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—lung cancer	0.00015	0.000207	CcSEcCtD
Quinidine barbiturate—Pruritus—Methotrexate—lung cancer	0.00015	0.000207	CcSEcCtD
Quinidine barbiturate—Urticaria—Doxorubicin—lung cancer	0.000145	0.000201	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—lung cancer	0.000145	0.0002	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Doxorubicin—lung cancer	0.000145	0.0002	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Methotrexate—lung cancer	0.000145	0.0002	CcSEcCtD
Quinidine barbiturate—Dizziness—Methotrexate—lung cancer	0.00014	0.000193	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—lung cancer	0.000135	0.000186	CcSEcCtD
Quinidine barbiturate—Vomiting—Methotrexate—lung cancer	0.000134	0.000186	CcSEcCtD
Quinidine barbiturate—Rash—Methotrexate—lung cancer	0.000133	0.000184	CcSEcCtD
Quinidine barbiturate—Dermatitis—Methotrexate—lung cancer	0.000133	0.000184	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—lung cancer	0.000132	0.000183	CcSEcCtD
Quinidine barbiturate—Asthenia—Doxorubicin—lung cancer	0.000131	0.000181	CcSEcCtD
Quinidine barbiturate—Pruritus—Doxorubicin—lung cancer	0.000129	0.000179	CcSEcCtD
Quinidine barbiturate—Nausea—Methotrexate—lung cancer	0.000126	0.000173	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Doxorubicin—lung cancer	0.000125	0.000173	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL6—lung cancer	0.000122	0.000647	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Doxorubicin—lung cancer	0.000121	0.000167	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.00012	0.000636	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BRAF—lung cancer	0.000119	0.000628	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000119	0.000627	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTM1—lung cancer	0.000119	0.000626	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	0.000117	0.000617	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MDM2—lung cancer	0.000117	0.000617	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Doxorubicin—lung cancer	0.000116	0.000161	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—RAF1—lung cancer	0.000116	0.000615	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000116	0.000613	CbGpPWpGaD
Quinidine barbiturate—Rash—Doxorubicin—lung cancer	0.000115	0.000159	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—lung cancer	0.000115	0.000159	CcSEcCtD
Quinidine barbiturate—Headache—Doxorubicin—lung cancer	0.000115	0.000158	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—AVP—lung cancer	0.000114	0.000603	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—lung cancer	0.000113	0.000599	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRM8—lung cancer	0.000113	0.000597	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6R—lung cancer	0.000113	0.000596	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CREBBP—lung cancer	0.000113	0.000595	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP1A1—lung cancer	0.000112	0.000593	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000111	0.000587	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000111	0.000586	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	0.000111	0.000585	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000111	0.000584	CbGpPWpGaD
Quinidine barbiturate—Nausea—Doxorubicin—lung cancer	0.000109	0.00015	CcSEcCtD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—POMC—lung cancer	0.000108	0.000571	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—JUN—lung cancer	0.000108	0.00057	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP2—lung cancer	0.000108	0.000569	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAP2K1—lung cancer	0.000108	0.000568	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—SRC—lung cancer	0.000105	0.000552	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AXL—lung cancer	0.000104	0.000548	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GRP—lung cancer	0.000103	0.000542	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—OXTR—lung cancer	0.000103	0.000542	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—lung cancer	0.000102	0.000538	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—NRAS—lung cancer	0.000101	0.000531	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MDM2—lung cancer	9.96e-05	0.000526	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—EP300—lung cancer	9.95e-05	0.000525	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—RAF1—lung cancer	9.92e-05	0.000524	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COL4A3BP—lung cancer	9.88e-05	0.000522	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AZIN2—lung cancer	9.88e-05	0.000522	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AVP—lung cancer	9.85e-05	0.00052	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	9.74e-05	0.000514	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—NRAS—lung cancer	9.66e-05	0.00051	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MAPK3—lung cancer	9.63e-05	0.000509	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNG11—lung cancer	9.6e-05	0.000507	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RAF1—lung cancer	9.54e-05	0.000504	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	9.49e-05	0.000501	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ERBB2—lung cancer	9.43e-05	0.000498	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	9.43e-05	0.000498	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—lung cancer	9.42e-05	0.000498	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GRP—lung cancer	9.32e-05	0.000492	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—OXTR—lung cancer	9.32e-05	0.000492	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—lung cancer	9.25e-05	0.000488	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—lung cancer	9.16e-05	0.000484	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—HRAS—lung cancer	9.1e-05	0.000481	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—lung cancer	8.8e-05	0.000465	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—APOA1—lung cancer	8.73e-05	0.000461	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNG11—lung cancer	8.72e-05	0.000461	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KRAS—lung cancer	8.66e-05	0.000457	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADCY1—lung cancer	8.64e-05	0.000456	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	8.59e-05	0.000454	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ATP5H—lung cancer	8.4e-05	0.000444	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—POMC—lung cancer	8.38e-05	0.000442	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—HRAS—lung cancer	8.36e-05	0.000442	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL8—lung cancer	8.36e-05	0.000441	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	8.33e-05	0.00044	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—lung cancer	8.31e-05	0.000439	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—lung cancer	8.09e-05	0.000427	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—COL4A2—lung cancer	8.07e-05	0.000426	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—HRAS—lung cancer	8.04e-05	0.000424	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PTHLH—lung cancer	8.03e-05	0.000424	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GIPR—lung cancer	7.86e-05	0.000415	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADCY1—lung cancer	7.84e-05	0.000414	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EP300—lung cancer	7.67e-05	0.000405	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP2R1B—lung cancer	7.64e-05	0.000404	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—lung cancer	7.64e-05	0.000403	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ANXA1—lung cancer	7.55e-05	0.000399	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLBD1—lung cancer	7.49e-05	0.000395	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SRC—lung cancer	7.46e-05	0.000394	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	7.45e-05	0.000393	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CREBBP—lung cancer	7.39e-05	0.00039	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—HRAS—lung cancer	7.36e-05	0.000389	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SDC4—lung cancer	7.34e-05	0.000388	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PTHLH—lung cancer	7.29e-05	0.000385	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—lung cancer	7.27e-05	0.000384	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—lung cancer	7.19e-05	0.00038	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DUSP3—lung cancer	7.19e-05	0.00038	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NRAS—lung cancer	7.18e-05	0.000379	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—APP—lung cancer	7.16e-05	0.000378	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	7.13e-05	0.000377	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RHEB—lung cancer	7.05e-05	0.000372	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—lung cancer	7.04e-05	0.000372	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—lung cancer	6.92e-05	0.000365	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK3—lung cancer	6.87e-05	0.000363	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ANXA1—lung cancer	6.85e-05	0.000362	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD17B10—lung cancer	6.85e-05	0.000362	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRM8—lung cancer	6.68e-05	0.000353	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	6.65e-05	0.000351	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—POMC—lung cancer	6.54e-05	0.000346	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—lung cancer	6.54e-05	0.000345	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—lung cancer	6.52e-05	0.000344	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—APP—lung cancer	6.5e-05	0.000343	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SKI—lung cancer	6.47e-05	0.000342	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—HRAS—lung cancer	6.41e-05	0.000338	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CKB—lung cancer	6.37e-05	0.000336	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.3e-05	0.000333	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	6.26e-05	0.00033	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—lung cancer	6.18e-05	0.000326	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM2—lung cancer	5.99e-05	0.000316	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CNDP2—lung cancer	5.99e-05	0.000316	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	5.9e-05	0.000312	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTMR3—lung cancer	5.82e-05	0.000308	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PGAM1—lung cancer	5.68e-05	0.0003	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PXN—lung cancer	5.62e-05	0.000297	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AVP—lung cancer	5.56e-05	0.000294	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—OXTR—lung cancer	5.5e-05	0.000291	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKR1C1—lung cancer	5.5e-05	0.000291	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRP—lung cancer	5.5e-05	0.000291	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—HRAS—lung cancer	5.46e-05	0.000289	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2A7—lung cancer	5.41e-05	0.000286	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	5.34e-05	0.000282	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SDC4—lung cancer	5.3e-05	0.00028	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HRAS—lung cancer	5.25e-05	0.000277	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNG11—lung cancer	5.15e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL8—lung cancer	5.06e-05	0.000267	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AVP—lung cancer	5.05e-05	0.000267	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—lung cancer	5.03e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFC—lung cancer	4.91e-05	0.000259	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—RRM1—lung cancer	4.83e-05	0.000255	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA3—lung cancer	4.83e-05	0.000255	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—lung cancer	4.64e-05	0.000245	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADCY1—lung cancer	4.63e-05	0.000245	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—B4GALT5—lung cancer	4.54e-05	0.00024	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP2R1B—lung cancer	4.51e-05	0.000238	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SMARCA4—lung cancer	4.51e-05	0.000238	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA4—lung cancer	4.41e-05	0.000233	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HSPB1—lung cancer	4.36e-05	0.00023	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTHLH—lung cancer	4.31e-05	0.000227	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA2—lung cancer	4.3e-05	0.000227	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA1—lung cancer	4.15e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCC3—lung cancer	4.1e-05	0.000217	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ANXA1—lung cancer	4.05e-05	0.000214	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKR1C1—lung cancer	3.97e-05	0.00021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FLT1—lung cancer	3.92e-05	0.000207	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	3.88e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UGT1A1—lung cancer	3.86e-05	0.000204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APP—lung cancer	3.84e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH3—lung cancer	3.84e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGF9—lung cancer	3.81e-05	0.000201	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNG11—lung cancer	3.72e-05	0.000196	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—POMC—lung cancer	3.7e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUNB—lung cancer	3.64e-05	0.000192	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALDOA—lung cancer	3.54e-05	0.000187	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	3.53e-05	0.000186	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOA3—lung cancer	3.44e-05	0.000182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	3.42e-05	0.00018	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—POMC—lung cancer	3.36e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADCY1—lung cancer	3.35e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCG2—lung cancer	3.35e-05	0.000177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STK11—lung cancer	3.3e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HPGDS—lung cancer	3.28e-05	0.000173	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENO2—lung cancer	3.28e-05	0.000173	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6R—lung cancer	3.28e-05	0.000173	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPP2R1B—lung cancer	3.26e-05	0.000172	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FOXO3—lung cancer	3.19e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTT1—lung cancer	3.18e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCLC—lung cancer	3.15e-05	0.000166	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2A6—lung cancer	3.15e-05	0.000166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	3.12e-05	0.000165	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	3.1e-05	0.000164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AVP—lung cancer	2.99e-05	0.000158	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENO1—lung cancer	2.98e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	2.98e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—lung cancer	2.87e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	2.86e-05	0.000151	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HES1—lung cancer	2.82e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAF1—lung cancer	2.77e-05	0.000146	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—lung cancer	2.73e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	2.7e-05	0.000143	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2E1—lung cancer	2.67e-05	0.000141	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NQO1—lung cancer	2.64e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL8—lung cancer	2.6e-05	0.000137	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB3—lung cancer	2.58e-05	0.000136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—lung cancer	2.48e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—lung cancer	2.47e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FGFR1—lung cancer	2.4e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—STK11—lung cancer	2.38e-05	0.000126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—lung cancer	2.37e-05	0.000125	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOA1—lung cancer	2.28e-05	0.000121	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—lung cancer	2.26e-05	0.000119	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—lung cancer	2.21e-05	0.000116	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAT—lung cancer	2.15e-05	0.000113	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—lung cancer	2.09e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—lung cancer	2.08e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KIT—lung cancer	2.08e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APC—lung cancer	2.08e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NRAS—lung cancer	2.08e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGF—lung cancer	2.06e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TYMS—lung cancer	2.05e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—lung cancer	2.03e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK3—lung cancer	2e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—POMC—lung cancer	1.98e-05	0.000105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—lung cancer	1.96e-05	0.000103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6R—lung cancer	1.94e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.93e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1A1—lung cancer	1.92e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ERCC2—lung cancer	1.91e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.9e-05	0.0001	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.84e-05	9.74e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.83e-05	9.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.81e-05	9.58e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.79e-05	9.47e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOA1—lung cancer	1.65e-05	8.7e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.65e-05	8.7e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MDM2—lung cancer	1.64e-05	8.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAF1—lung cancer	1.64e-05	8.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.62e-05	8.55e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.6e-05	8.43e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MTOR—lung cancer	1.6e-05	8.43e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.53e-05	8.1e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.52e-05	8.05e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—lung cancer	1.5e-05	7.95e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.48e-05	7.83e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—lung cancer	1.47e-05	7.76e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—lung cancer	1.47e-05	7.74e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—lung cancer	1.46e-05	7.71e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—POMC—lung cancer	1.43e-05	7.56e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—lung cancer	1.43e-05	7.55e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUN—lung cancer	1.43e-05	7.53e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CREBBP—lung cancer	1.4e-05	7.37e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—lung cancer	1.39e-05	7.33e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.38e-05	7.3e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTEN—lung cancer	1.38e-05	7.29e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.35e-05	7.11e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CD—lung cancer	1.32e-05	6.99e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EP300—lung cancer	1.32e-05	6.95e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—lung cancer	1.31e-05	6.9e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SRC—lung cancer	1.28e-05	6.76e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.25e-05	6.58e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—lung cancer	1.23e-05	6.52e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NRAS—lung cancer	1.23e-05	6.5e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.18e-05	6.23e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CB—lung cancer	1.15e-05	6.09e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—lung cancer	1.15e-05	6.06e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—lung cancer	1.14e-05	6.03e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—lung cancer	1.12e-05	5.92e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—lung cancer	1.06e-05	5.6e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTEN—lung cancer	9.96e-06	5.26e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—lung cancer	9.73e-06	5.14e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EP300—lung cancer	9.5e-06	5.02e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—lung cancer	9.42e-06	4.97e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRAS—lung cancer	9.01e-06	4.76e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—lung cancer	8.62e-06	4.55e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—lung cancer	7.95e-06	4.2e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—lung cancer	7.03e-06	3.71e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—lung cancer	5.74e-06	3.03e-05	CbGpPWpGaD
